Clinical Trial Update: Phase II/III Clinical Study CSF470 Plus BCG Plus GM-CSF vs IFN Alpha 2b in Stage IIB, IIC and III Melanoma Patients [Phase 2, Phase 3]

View source ↗

Summary

A Phase II/III clinical trial comparing CSF470 plus BCG plus GM-CSF versus interferon alpha-2b in patients with stage IIB/IIC and III cutaneous melanoma; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Melanoma

Drugs mentioned

• Bacillus Calmette-Guérin (BCG) (Bacillus Calmette-Guérin)
• CSF470 (CSF470)
• GM-CSF (granulocyte-macrophage colony-stimulating factor)
• Interferon-alpha-2b (interferon alfa-2b)

Snippet

Sponsor: Laboratorio Pablo Cassará S.R.L. | Conditions: Cutaneous Melanoma | Phase 2, Phase 3 | Status: UNKNOWN